Memantine is indicated for the treatment of moderate to severe Alzheimer’s Disease (AD).
Unipharm’s generic Memantine HCl Tablets have been manufactured and marketed in Israel since 2006.
ATC4: N06DX
Strengths: 10 & 20 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
